Artesunate Injection IP 60mg (UNDER DPCO)

Send Inquiry

Request To Call Back

Artesunate Injection IP 60mg (UNDER DPCO)

Name: Artesunate Injection IP 60mg (UNDER DPCO)
Brand: MONARK BIOCARE PRIVATE LIMITED
Price: 240.0 INR
Availability: InStock

Price 240.0 INR/ Vial

Get a Price/Quote

Artesunate Injection IP 60mg (UNDER DPCO) Specification

Packaging Type
7.5ML VIAL

Salt Composition
Artesunate Injection IP 60mg (UNDER DPCO)

Life Span
24 Months

Brand Name
Arteark-60

Drug Type
Injection

Ingredients
Artesunate Injection IP 60mg (under DPCO) is a sterile lyophilized powder vial containing 60mg artesunate for IV/IM reconstitution, included in India's Drug Price Control Order (DPCO) for affordable severe malaria treatment. Designed for pediatric patients or smaller adults, it rapidly converts to dihydroartemisinin to generate free radicals that alkylate Plasmodium falciparum proteins, treating severe malaria including cerebral cases when oral therapy fails.

Physical Form
Liquid

Quantity
1 Unit

Storage Instructions
cool & dry place

Artesunate Injection IP 60mg (UNDER DPCO) Trade Information

Minimum Order Quantity
100 Number

Supply Ability
1000 Per Month

Delivery Time
5 Days

About Artesunate Injection IP 60mg (UNDER DPCO)

Artesunate Injection IP 60mg (UNDER DPCO) is a sterile powder for injection containing 60 mg artesunate per vial, a water-soluble artemisinin derivative used for rapid IV treatment of severe falciparum malaria.
The kit typically includes a 5 mL vial of artesunate powder, 1 mL ampoule of 5% sodium bicarbonate for reconstitution (to achieve pH 7-8.5), 5 mL 0.9% sodium chloride diluent, syringe, and needle; it's administered IV over 1-2 minutes after mixing, followed by oral therapy.

Rapid Malaria Treatment

Arteark-60 is specially developed to deliver swift and effective results in managing severe malaria infections. By utilizing artesunate as the primary active ingredient, this injection ensures prompt therapeutic intervention in acute cases. Its lyophilized powder form allows for easy reconstitution and immediate administration, accelerating the patient's recovery process.

Reliable Quality & Compliance

Manufactured under stringent standards and in compliance with DPCO regulations, Arteark-60 promises assured quality and affordability. Each unit undergoes rigorous testing for purity and safety, offering confidence to healthcare professionals and patients alike. Supplied by reputable distributors, manufacturers, and suppliers across India, this injection meets the specific clinical needs for malaria management.

FAQ's of Artesunate Injection IP 60mg (UNDER DPCO):

Q: How should Artesunate Injection IP 60mg (Arteark-60) be administered?

A: Arteark-60 must be reconstituted with an appropriate solvent prior to intravenous (IV) or intramuscular (IM) injection by a qualified healthcare provider, ensuring correct dosage and sterile technique for optimal safety and efficacy.

Q: What conditions is Arteark-60 primarily used to treat?

A: Arteark-60 is indicated for the treatment of severe malaria, especially when oral therapy is not possible or effective. Its fast-acting formulation is recommended during acute malaria episodes to rapidly reduce parasite levels in the bloodstream.

Q: When should Arteark-60 be used instead of oral antimalarials?

A: Arteark-60 is reserved for cases where patients present with severe or complicated malaria, or when patients are unable to swallow or absorb oral medications, necessitating intravenous or intramuscular administration.

Q: Where should Arteark-60 be stored to maintain its effectiveness?

A: The injection should be kept in a cool and dry place, away from direct sunlight and moisture, to maintain its potency and extend its shelf life up to 24 months.

Q: What is the process for reconstituting and administering Arteark-60?

A: A healthcare professional should dissolve the lyophilized powder in the vial with sterile solvent, mixing until a clear solution is formed. The prepared solution is then administered either intravenously or intramuscularly, as prescribed.

Q: What are the main benefits of using Arteark-60 for malaria treatment?

A: Arteark-60 offers rapid onset of action against malaria parasites, high efficacy in severe cases, and flexibility in administration (IV/IM). Its quality assurance and DPCO-compliant pricing also support widespread accessibility in India.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Analgesic & Anti-inflammatory Drugs - Nsaids Category

Vancomycin Hydrochloride 1000 MG For Intravenous Infusion IP

Price 502.37 INR / Vial

Minimum Order Quantity : 100

Ingredients : Vancomycin Hydrochloride 1000 mg for Intravenous Infusion IP is a sterile lyophilized powder vial containing 1000 mg vancomycin base (as hydrochloride) for reconstitution and IV infusion only. It inhibits bacterial cell wall synthesis by binding DAlaDAla terminus, treating serious Grampositive infections including MRSA bacteremia, endocarditis, complicated skin/soft tissue infections, pneumonia, bone/joint infections, and C. difficile colitis when oral therapy fails.

Physical Form : Liquid

Brand Name : Ancolase1000

Get a Price/Quote

Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet

Price 1368.75 INR / Number

Minimum Order Quantity : 100

Ingredients : Metformin (SR) 500 mg + Pioglitazone HCl 15 mg + Glimepiride 2 mg Bilayered Tablet combines sustainedrelease metformin (hepatic glucose suppression), pioglitazone (PPAR agonist improving insulin sensitivity/adipocyte differentiation), and glimepiride (sulfonylurea stimulating insulin secretion) for comprehensive type 2 diabetes management. Triple therapy targets insulin resistance, betacell dysfunction, and hepatic gluconeogenesis, achieving HbA1c reductions of 2.22.8% in patients uncontrolled on dual therapy; pioglitazone provides additional benefits in dyslipidemia (TG 15%, HDL 10%) and atherosclerosis regression. Adults: 1 tablet once daily with meals; side effects include hypoglycemia (1520%), weight gain/edema (pioglitazone), GI upset (less with SR), HF risk (monitor NYHA Class I/II only); contraindicated in DKA, eGFR<30, bladder cancer history; check LFTs, echo periodically.

Physical Form : Tablets

Brand Name : GLIMLASEPG2

Get a Price/Quote